Literature DB >> 15702084

Myxoid malignant fibrous histiocytoma and pleomorphic liposarcoma share very similar genomic imbalances.

Ahmed Idbaih1, Jean-Michel Coindre, Josette Derré, Odette Mariani, Philippe Terrier, Dominique Ranchère, Aline Mairal, Alain Aurias.   

Abstract

Malignant fibrous histiocytoma (MFH) is the most common soft tissue sarcoma. Nevertheless, the validity of this heterogeneous pathological entity has been recurrently questioned by pathologists. Recently, analyses by comparative genomic hybridization (CGH) of a large series of MFHs suggested that MFHs consist of morphologic modulation of other poorly differentiated sarcomas like leiomyosarcomas (LMS) or dedifferentiated liposarcomas (DLPS). We report here an analysis by CGH of 22 myxoid MFHs (mMFH), one of the five histological subtypes of MFH, and of nine pleomorphic liposarcomas (pLPS), a rare poorly differentiated LPS. The chromosome imbalances encountered in the series of mMFH were very similar to those observed in the series of pLPS studied in the laboratory and in the series of 14 pLPS published in the literature. The most frequent gains involved chromosome subregions: pericentromeric regions of 1, 5p, 19p, 19q and 20q. Losses found in the chromosomal arms 1q, 2q, 3p, 4q, 10q, 11q and 13q were also recurrent. The use of a clustering software did not separate the two pathological groups (mMFH and pLPS) on the basis of genomic data. Moreover, pLPS-mMFH represented, according to the clustering software results, an entity clearly distinguished from other soft tissue sarcomas, LMS in particular, with which they share common genetic aberrations. Additional studies are needed to identify genes targeted by these genomic aberrations, and implicated in the oncogenesis of these tumor subtypes. The characterization of common gene alterations in both tumor groups would suggest a closer relationship between these two types of soft tissue sarcomas.

Entities:  

Mesh:

Year:  2005        PMID: 15702084     DOI: 10.1038/labinvest.3700202

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  27 in total

1.  Cytogenetic analysis of myxoid liposarcoma and myxofibrosarcoma by array-based comparative genomic hybridisation.

Authors:  T Ohguri; M Hisaoka; S Kawauchi; K Sasaki; T Aoki; S Kanemitsu; A Matsuyama; Y Korogi; H Hashimoto
Journal:  J Clin Pathol       Date:  2006-06-02       Impact factor: 3.411

Review 2.  Advances in sarcoma genomics and new therapeutic targets.

Authors:  Barry S Taylor; Jordi Barretina; Robert G Maki; Cristina R Antonescu; Samuel Singer; Marc Ladanyi
Journal:  Nat Rev Cancer       Date:  2011-07-14       Impact factor: 60.716

3.  Myxoid liposarcoma with cartilaginous differentiation showing DDIT3 rearrangement.

Authors:  Kayo Suzuki; Taketoshi Yasuda; Kenta Watanabe; Takeshi Hori; Masahiko Kanamori; Tomoatsu Kimura
Journal:  Oncol Lett       Date:  2017-09-25       Impact factor: 2.967

Review 4.  Soft tissue sarcomas with complex genomic profiles.

Authors:  Louis Guillou; Alain Aurias
Journal:  Virchows Arch       Date:  2010-02       Impact factor: 4.064

Review 5.  [Pleomorphic high-grade soft tissue sarcomas: is the subclassification up to date?].

Authors:  G Mechtersheimer; M Renner; R Penzel; P Schirmacher
Journal:  Pathologe       Date:  2011-02       Impact factor: 1.011

Review 6.  Genomic characteristics of soft tissue sarcomas.

Authors:  Fredrik Mertens; Ioannis Panagopoulos; Nils Mandahl
Journal:  Virchows Arch       Date:  2009-02-03       Impact factor: 4.064

7.  Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience.

Authors:  Ronald S A de Vreeze; Daphne de Jong; Petra M Nederlof; Aafke Ariaens; Ivon H G Tielen; Luc Frenken; Rick L Haas; Frits van Coevorden
Journal:  Ann Surg Oncol       Date:  2010-03       Impact factor: 5.344

8.  Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy.

Authors:  Jordi Barretina; Barry S Taylor; Shantanu Banerji; Alexis H Ramos; Mariana Lagos-Quintana; Penelope L Decarolis; Kinjal Shah; Nicholas D Socci; Barbara A Weir; Alan Ho; Derek Y Chiang; Boris Reva; Craig H Mermel; Gad Getz; Yevgenyi Antipin; Rameen Beroukhim; John E Major; Charles Hatton; Richard Nicoletti; Megan Hanna; Ted Sharpe; Tim J Fennell; Kristian Cibulskis; Robert C Onofrio; Tsuyoshi Saito; Neerav Shukla; Christopher Lau; Sven Nelander; Serena J Silver; Carrie Sougnez; Agnes Viale; Wendy Winckler; Robert G Maki; Levi A Garraway; Alex Lash; Heidi Greulich; David E Root; William R Sellers; Gary K Schwartz; Cristina R Antonescu; Eric S Lander; Harold E Varmus; Marc Ladanyi; Chris Sander; Matthew Meyerson; Samuel Singer
Journal:  Nat Genet       Date:  2010-07-04       Impact factor: 38.330

9.  DNA copy number changes in human malignant fibrous histiocytomas by array comparative genomic hybridisation.

Authors:  Stine H Kresse; Hege O Ohnstad; Bodil Bjerkehagen; Ola Myklebost; Leonardo A Meza-Zepeda
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

10.  Pleomorphic Liposarcoma Arising in a Lipoleiomyosarcoma of the Uterus: Report of a Case With Genetic Profiling by a Next Generation Sequencing Panel.

Authors:  J Kenneth Schoolmeester; Michael D Stamatakos; Ann M Moyer; Kay J Park; Melissa Fairbairn; Amanda N Fader
Journal:  Int J Gynecol Pathol       Date:  2016-07       Impact factor: 2.762

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.